The GLP-1 paradox: too expensive to cover, too effective to cut
A founder and a former HHS CTO agree: GLPs are breaking the healthcare system. We need to move away from drug-first or diet-first obesity care.
Comments 0
Log in to join the conversation.
No comments yet. Be the first to share your thoughts!